Innovating.works Conecta tu I+D

ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-07 The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado

SCARLET: Scaling up early and late effects research in Lithuanian childhood cancer survivors through educatio... VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS tramitó un HORIZON EUROPE: HORIZON-WIDERA-2023-ACCESS-02 The SCARLET (SCAling up early and late effects Research in Lithuanian childhood cancer survivors through Education and Twinning) proposal ai...
2024-05-07 - 2027-09-30 | Financiado

eprObes: Preventing lifetime obesity by early risk factor identification prognosis and intervention VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS participó en un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-two-stage Obesity is one of the main population health threats worldwide, with a sustained increase in prevalence over the last decades and a constell...
2023-04-11 - 2028-04-30 | Financiado

4.UNCAN.eu: A Coordination and Support Action to prepare UNCAN.eu platform VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS participó en un HORIZON EUROPE: HORIZON-MISS-2021-UNCAN-01 The 15-month coordination and support action 4.UNCAN.eu will generate a strategic agenda to launch UNCAN.eu, a European initiative to UNders...
2022-05-17 - 2023-11-30 | Financiado

EuCARE: European Cohorts of Patients and Schools to Advance Response to Epidemics VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS participó en un HORIZON EUROPE: HORIZON-HLTH-2021-CORONA-01 The EuCARE project gathers a comprehensive multidisciplinary team of clinicians, virologists, epidemiologists, statisticians and top experts...
2021-11-15 - 2026-10-13 | Financiado

VACCELERATE: VACCELERATE European Corona Vaccine Trial Accelerator Platform VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS participó en un H2020: The ongoing COVID-19 pandemic creates an unprecedented burden worldwide. Vaccine-induced immunity is the only promising solution. There is c...
2021-02-17 - 2024-01-27 | Financiado

PanCareSurPass: PanCare studies of the scale up and implementation of the digital Survivorship Passport to improve p... VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS participó en un H2020: H2020-SC1-BHC-2018-2020 Almost 500,000 former childhood cancer patients (CCS) are now living in Europe. Compared to the general population, CCS represent a vulnerab...
2021-01-21 - 2025-02-28 | Financiado

TREL: Twinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS tramitó un H2020: H2020-WIDESPREAD-2018-2020 Vilnius University Hospital Santaros Klinikos (VULSK) acts as a coordinator of the TREL (Twinning in Research and Education to improve survi...
2020-06-12 - 2023-12-31 | Financiado

EJP RD: European Joint Programme on Rare Diseases VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS participó en un H2020: H2020-SC1-BHC-2018-2020 As recognized by the Council Recommendation 2009/C 151/02, rare diseases (RD) are a prime example of a research area that can strongly profi...
2018-12-13 - 2024-08-31 | Financiado

CARE: COMMON ACTION AGAINST HIV TB HCV ACROSS THE REGIONS OF EUROPE VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS participó en un H2020: H2020-SC1-BHC-2018-2020 CARE brings together distinguished scientists and highly representative networks in the European region, including Russia, in the fight agai...
2018-11-21 - 2021-06-30 | Financiado

EUROHYP-1: European multicentre randomised phase III clinical trial of hypothermia plus best medical treatmen... VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS participó en un FP7: The consortium led by UKER and EuroHYP, the European Stroke Research Network for Hypothermia, proposes a large, multicentre clinical trial w...
Financiado

NEOMERO: European multicenter network to evaluate pharmacokinetics safety and efficacy of Meropenem in neona... VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS participó en un FP7: Previous studies have demonstrated the high frequency of bacterial sepsis in neonates and infants admitted to neonatal intensive care unit (...
Financiado

TB PAN-NET: Pan European network for the study and clinical management of drug resistant tuberculosis VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS participó en un FP7: This proposal will establish an integrated and synergistic network to address the challenge of multiple drug resistant tuberculosis (MDR-TB)...
Financiado

CULPRIT-SHOCK: Multivessel versus culprit lesion only percutaneous revascularization in patients with acute myocard... VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS participó en un FP7: Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) represents a major European health care concern with mortality rates b...
Financiado

CARRE: Personalized patient empowerment and shared decision support for cardiorenal disease and comorbiditi... VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS participó en un FP7: CARRE addresses comorbidity management via an approach that first fosters understanding of the complex interdependent nature of comorbiditie...
Financiado

AIDPATH: Academia and Industry Collaboration for Digital Pathology VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS participó en un FP7: Advances in digital pathology are generating huge volumes of whole slide and tissue microarray images which are providing new insights into...
Financiado